{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:55:27Z","timestamp":1771487727035,"version":"3.50.1"},"reference-count":43,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4,1]]},"DOI":"10.1210\/jc.2006-2716","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T22:44:35Z","timestamp":1170456275000},"page":"1347-1352","source":"Crossref","is-referenced-by-count":40,"title":["Pharmacokinetic Factors Contribute to the Inverse Relationship between Luteinizing Hormone and Body Mass Index in Polycystic Ovarian Syndrome"],"prefix":"10.1210","volume":"92","author":[{"given":"Serene S.","family":"Srouji","sequence":"first","affiliation":[{"name":"Reproductive Endocrine Unit (S.S.S., Y.L.P., A.D., Y.J., J.E.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"},{"name":"Center for Reproductive Medicine, Department of Obstetrics and Gynecology (S.S.S.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanira L.","family":"Paga\u0301n","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit (S.S.S., Y.L.P., A.D., Y.J., J.E.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"D\u2019Amato","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology (F.D., J.G.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amsalu","family":"Dabela","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit (S.S.S., Y.L.P., A.D., Y.J., J.E.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yarisie","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit (S.S.S., Y.L.P., A.D., Y.J., J.E.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey G.","family":"Supko","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology (F.D., J.G.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Hall","sequence":"additional","affiliation":[{"name":"Reproductive Endocrine Unit (S.S.S., Y.L.P., A.D., Y.J., J.E.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113510779700_R1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/jcem-30-4-435","article-title":"Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease.","volume":"30","author":"Yen","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113510779700_R3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R4","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R5","first-page":"3728","article-title":"Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.","volume":"82","author":"Arroyo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2005-2099","article-title":"Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.","volume":"91","author":"Pagan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R7","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jps.20125","article-title":"Pharmacokinetic aspects of biotechnology products.","volume":"93","author":"Tang","year":"2004","journal-title":"J Pharm Sci"},{"key":"key\n\t\t\t\t2019041113510779700_R8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/js980173a","article-title":"Pharmacokinetic considerations in obesity.","volume":"88","author":"Blouin","year":"1999","journal-title":"J Pharm Sci"},{"key":"key\n\t\t\t\t2019041113510779700_R9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0021-9258(19)57352-5","article-title":"Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones.","volume":"263","author":"Green","year":"1988","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113510779700_R10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1507\/endocrj.40.73","article-title":"Comparison of biological aspects among ovine luteinizing hormone isoforms with charge heterogeneity.","volume":"40","author":"Nakamura","year":"1993","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t2019041113510779700_R11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0303-7207(96)03958-5","article-title":"Structural and functional characterisation of hFSH and hLH isoforms.","volume":"125","author":"Stanton","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"key\n\t\t\t\t2019041113510779700_R12","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1210\/endo.137.11.8895353","article-title":"In vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms.","volume":"137","author":"Burgon","year":"1996","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113510779700_R13","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1073\/pnas.90.23.11127","article-title":"Estrogen modulates expression of the glycosyltransferases that synthesize sulfated oligosaccharides on lutropin.","volume":"90","author":"Dharmesh","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113510779700_R14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/endo-106-6-1941","article-title":"Modulation of serum and pituitary luteinizing hormone bioactivity by androgen in the rat.","volume":"106","author":"Solano","year":"1980","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113510779700_R15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2265.1994.tb03786.x","article-title":"Less acidic forms of luteinizing hormone are associated with lower testosterone secretion in men on haemodialysis treatment.","volume":"41","author":"Mitchell","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113510779700_R16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0739-7240(97)00082-9","article-title":"Ovine luteinizing hormone heterogeneity: androgens increase the percentage of less basic isohormones.","volume":"15","author":"Christianson","year":"1998","journal-title":"Domest Anim Endocrinol"},{"key":"key\n\t\t\t\t2019041113510779700_R17","first-page":"4603","article-title":"A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.","volume":"85","author":"Castro-Fernandez","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1971","journal-title":"J Clin Endocrinol"},{"key":"key\n\t\t\t\t2019041113510779700_R19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113510779700_R20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/jcem-72-6-1278","article-title":"Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.","volume":"72","author":"Christman","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R21","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1073\/pnas.91.15.6894","article-title":"Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.","volume":"91","author":"Hall","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113510779700_R22","first-page":"2343","article-title":"Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.","volume":"83","author":"Hayes","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R23","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1210\/jc.2002-021516","article-title":"Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition.","volume":"88","author":"Welt","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R24","first-page":"105","article-title":"Female reproductive aging is marked by decreased secretion of dimeric inhibin.","volume":"84","author":"Welt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R25","doi-asserted-by":"crossref","unstructured":"Gibaldi G, Perrier D 1982 Pharmacokinetics. 2nd ed. New York: Marcel Dekker, Inc.","DOI":"10.1201\/b14095"},{"key":"key\n\t\t\t\t2019041113510779700_R26","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113510779700_R28","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1248\/cpb.33.1620","article-title":"Preparation of mean drug concentration\u2013time curves in plasma. A study on the frequency distribution of pharmacokinetic parameters.","volume":"33","author":"Mizuta","year":"1985","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"key\n\t\t\t\t2019041113510779700_R29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10543409708835177","article-title":"Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed?","volume":"7","author":"Lacey","year":"1997","journal-title":"J Biopharm Stat"},{"key":"key\n\t\t\t\t2019041113510779700_R30","first-page":"1","article-title":"The Jacknife\u2014a review.","volume":"61","author":"Miller","year":"1974","journal-title":"Biometrika"},{"key":"key\n\t\t\t\t2019041113510779700_R31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1172\/JCI105713","article-title":"Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women.","volume":"47","author":"Kohler","year":"1968","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113510779700_R32","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1210\/jcem-28-12-1763","article-title":"Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man.","volume":"28","author":"Yen","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI112411","article-title":"Metabolic clearance of biologically active luteinizing hormone in man.","volume":"77","author":"Veldhuis","year":"1986","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113510779700_R34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0015-0282(97)00501-3","article-title":"Clinical pharmacology of recombinant human luteinizing hormone: part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone.","volume":"69","author":"Cotonnec","year":"1988","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113510779700_R35","first-page":"688","article-title":"Disappearance of endogenous luteinizing hormone is prolonged in postmenopausal women.","volume":"84","author":"Sharpless","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113510779700_R36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/0091270004269520","article-title":"Population pharmacokinetics of erythropoietin in critically ill subjects.","volume":"45","author":"Chakraborty","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041113510779700_R37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s002280000230","article-title":"Consideration of endogenous backgrounds in pharmacokinetic analyses: a simulation study.","volume":"56","author":"Schindel","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041113510779700_R38","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/endo.137.5.8612480","article-title":"Glycosylation: to what end for the glycoprotein hormones?","volume":"137","author":"Baenziger","year":"1996","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113510779700_R39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000127152","article-title":"GnRH-stimulated glycosylation (proximal and distal) of luteinizing hormone by cultured rat pituitary cells.","volume":"64","author":"Perez","year":"1996","journal-title":"Neuroendocrinology"},{"key":"key\n\t\t\t\t2019041113510779700_R40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/endo-98-1-151","article-title":"Effects of synthetic gonadotropin-releasing hormone on incorporation of radioactive glucosamine and amino acids into luteinizing hormone and total protein by rat pituitaries in vitro.","volume":"98","author":"Liu","year":"1976","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113510779700_R41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/acta.0.1090181","article-title":"Median charge and charge heterogeneity of human pituitary FSH, LH and TSH. I. Zone electrophoresis in agarose suspension.","volume":"109","author":"Wide","year":"1985","journal-title":"Acta Endocrinol (Copenh)"},{"key":"key\n\t\t\t\t2019041113510779700_R42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2265.1994.tb02513.x","article-title":"17 \u03b2-Oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause.","volume":"40","author":"Wide","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113510779700_R43","first-page":"4629","article-title":"A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome.","volume":"84","author":"Ropelato","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/4\/1347\/9053224\/jcem1347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T07:22:45Z","timestamp":1628407365000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/4\/1347\/2597222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-2716","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,1]]}}}